Anti-CDC42 binding protein kinase alpha antibody
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Polyclonal CDC42 binding protein kinase alpha antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CDC42BPA aa 350-600.
View Alternative Names
KIAA0451, CDC42BPA, Serine/threonine-protein kinase MRCK alpha, CDC42-binding protein kinase alpha, DMPK-like alpha, Myotonic dystrophy kinase-related CDC42-binding kinase alpha, MRCK alpha, Myotonic dystrophy protein kinase-like alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDC42 binding protein kinase alpha antibody (AB96659)
ab96659 staining CDC42 binding protein kinase alpha in SW480 xenograft at 1/100 dilution by Immunohistochemistry (Formalin/PFA-Fixed Paraffin-embedded sections)
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Animal nutrition (Zhongguo xu mu shou yi xue hui) 10:319-328 PubMed35891685
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 13: PubMed32071169
2020
Applications
Unspecified application
Species
Unspecified reactive species
Schizophrenia research 201:270-277 PubMed29759351
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 78:2096-2114 PubMed29382705
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 10:2359-2365 PubMed26622852
2015
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com